Adverse events and tolerability of the combination of fluoxetine/lithium compared with fluoxetine

被引:17
作者
Bauer, M
Linden, M
Schaaf, B
Weber, HJ
机构
[1] FACTUM,OFFENBACH,GERMANY
[2] LILLY DEUTSCHLAND,HOMBURG,GERMANY
关键词
D O I
10.1097/00004714-199604000-00005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Data from an intensive observational drug utilization study were analyzed to determine whether patients who received the combination of fluoxetine and lithium had more and different adverse events as compared with those receiving fluoxetine alone. In a matched cohort control design, we compared 110 patients per group. Results showed no significant difference in side effects between groups. Also, the incidence of ''serotonergic'' adverse events showed no significant differences between groups during the 7-week study period. In conclusion, the results show that the combination of fluoxetine/lithium is generally well tolerated in spite of a somewhat increased rate of minor side effects.
引用
收藏
页码:130 / 134
页数:5
相关论文
共 23 条
[1]  
BAUER M, 1995, J SEROTONIN RES, V2, P69
[2]  
BREUEL HP, 1995, INT J CLIN PHARM TH, V33, P415
[3]   FLUOXETINE DRUG-DRUG INTERACTIONS .1. ANTIDEPRESSANTS AND ANTIPSYCHOTICS [J].
CIRAULO, DA ;
SHADER, RI .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1990, 10 (01) :48-50
[4]   THE SAFETY OF FLUOXETINE - AN UPDATE [J].
COOPER, GL .
BRITISH JOURNAL OF PSYCHIATRY, 1988, 153 :77-86
[5]  
DEMONTIGNY C, 1983, ARCH GEN PSYCHIAT, V40, P1327
[6]  
FAVA M, 1994, AM J PSYCHIAT, V151, P1372
[7]  
Feighner J P., 1991, Selective serotonin re-uptake inhibitors: the clinical use o f Citalopram, Fluoxetine, Fluvoxamine, Paroxetine, and Sertraline
[8]  
HADLEY A, 1989, AM J PSYCHIAT, V146, P1637
[9]   TOLERABILITY OF COMBINED TREATMENT WITH LITHIUM AND FLUOXETINE - 14 CASES TREATED UNDER OPEN CONDITIONS [J].
HAWLEY, CJ ;
ROBERTS, AG ;
BALDWIN, DS .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1994, 9 (01) :31-33
[10]   THE COMBINATION OF FLUOXETINE AND LITHIUM IN CLINICAL-PRACTICE [J].
HOPWOOD, SE ;
BOGLE, S ;
WILDGUST, HJ .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1993, 8 (04) :325-327